Compare AbCellera Biologics Inc (ABCL) vs Micron Technology, Inc. (MU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Micron Technology, Inc. — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while Micron Technology, Inc. trades at $892.45 (market cap $980.90B). The key difference: Micron Technology, Inc. is far larger — about 328.1× AbCellera Biologics Inc's market cap, and Micron Technology, Inc. pays a 0.06% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | MU | |
|---|---|---|
Market Cap | $2.99B | $980.90B |
Sector | Health | Technology |
52-Week High | $9.76 | $1.21K |
52-Week Low | $2.78 | $115.79 |
Enterprise Value | $2.58B | $961.25B |
Dividend Yield | — | 0.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Micron Technology, Inc.
Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →
